Time for Episwitch to be adopted. Current screening woefully inadequate. PSA very unreliable, MRI a big waste in a number of cases. Fewer biopsies too. NHS adoption is hard work and can take years (see FDBK). NICE need to take a long look.
The key issue is whether the ICBs or Trusts are interested in Bleepa. QVH were but not at the tender headline price of Β£1.6m. Dibs makes a good point. Hopefully funds will be available in 2025.